Aspergillus biofilms in human disease

Craig Williams, Ranjith Rajendran, Gordon Ramage

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

15 Citations (Scopus)


The biofilm phenotype of Aspergillus species is an important and accepted clinical entity. While industrially these biofilms have been used extensively in important biofermentations, their role in clinical infection is less well defined. A recent flurry of activity has demonstrated that these interesting filamentous moulds have the capacity to form biofilms both in vitro and in vivo, and through various investigations have shown that these are exquisitely resistant to antifungal therapies through a range of adaptive resistance mechanisms independent of defined genetic changes. This review will explore the clinical importance of these biofilms and provide contemporary information with respect to their clinical management.
Original languageEnglish
Title of host publicationAdvances in Experimental Medicine and Biology
Place of PublicationBoston, MA
Number of pages11
Publication statusPublished - 7 Jun 2016

Publication series

NameAdvances in Experimental Medicine and Biology
PublisherSpringer US
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019


  • Aspergillus biofilm
  • Filamentous moulds
  • Fungal infections
  • Aspergillosis
  • Antifungal drugs


Dive into the research topics of 'Aspergillus biofilms in human disease'. Together they form a unique fingerprint.

Cite this